| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10761189 | Biochemical and Biophysical Research Communications | 2012 | 6 Pages |
Abstract
⺠Sorafenib treatment upregulated GSK-3β levels in RCC cells. ⺠Pharmacologic inhibition of GSK-3 suppressed xenograft RCC tumor growth. ⺠Inhibition of GSK-3 enhanced antitumor effect of sorafenib in vitro and in vivo.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hisashi Kawazoe, Vladimir N. Bilim, Andrey V. Ugolkov, Kaori Yuuki, Sei Naito, Akira Nagaoka, Tomoyuki Kato, Yoshihiko Tomita,